Remus Pharmaceuticals Ltd.

7833.65 -433.60 ▼-5.2%

25 April 2024, 03:58:41 PM
Volume: 10,400

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.remuspharma.com
Market Cap 1,217.77 Cr.
Enterprise Value(EV) 1,219.94 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 57.73 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 143.22 Trailing Twelve Months Ending 2023-03
Industry PE 41.30 Trailing Twelve Months Ending 2023-03
Book Value / Share 453.64 Trailing Twelve Months Ending 2023-03
Price to Book Value 18.22 Calculated using Price: 8,267.25
Dividend Yield 0.02 Period Ending 2023-03
No. of Shares Subscribed 0.15 Cr. 1,473,000 Shares
FaceValue 10
About Remus Pharmaceuticals Ltd.
The company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Having cultivated strong and dependable customer relationships ranging from Generic distributors, regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network, its clients are spread in various countries

Remus Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Remus Pharmaceuticals Ltd. Performance

1 Day
-5.24%
1 Week
+32.80%
1 Month
+32.97%
3 Month
+25.71%
6 Month
+41.53%
1 Year
2 Year
5 Year
10 Year

Remus Pharmaceuticals Ltd. Fundamental Ratios

4 years 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 40.17 40.49 71.37 66.14
Return on Capital Employed (%) 47.76 48.84 93.13 68.82
Return on Assets (%) 15.38 12.61 25.62 33.77

Remus Pharmaceuticals Ltd. Balance Sheet

Particulars 5 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2 3 7 19 74
Non Curr. Liab. 0 0 0 7 2
Curr. Liab. 3 8 9 8 12
Minority Int.
Equity & Liab. 5 11 16 35 88
Non Curr. Assets 1 3 8 23 24
Curr. Assets 5 8 8 11 64
Misc. Exp. not W/O
Total Assets 5 11 16 35 88

Remus Pharmaceuticals Ltd. Profit and Loss

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 12 18 25 45
Other Income 1 1 1 2
Total Income 13 19 25 47
Total Expenditure -12 -18 -21 -34
PBIDT 1 2 5 12
Interest 0 0 0 0
Depreciation 0 0 0 0
Taxation 0 0 -1 -3
Exceptional Items
PAT 1 1 3 9
Adjusted EPS 8 10 34 78

Remus Pharmaceuticals Ltd. Cash Flow

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 3 5 5
Cash Fr. Inv. -1 -3 -5 -15
Cash Fr. Finan. 0 0 0 12
Net Change 1 0 0 2
Cash & Cash Eqvt 1 1 1 3

Remus Pharmaceuticals Ltd. Shareholding Pattern

2 Qtrs 2023-09 (%) 2024-03 (%)
Promoter 69.61 70.60
Public 30.39 29.40
Depository Receipts 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00
No. of Shareholders (in Lacs)

Remus Pharmaceuticals Ltd. Announcements

Tue, 23 Apr 2024
Outcome of Board Meeting
Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board meeting held on April 23, 2024.
Tue, 23 Apr 2024
Bonus
Remus Pharmaceuticals Limited has informed the Exchange about Bonus
Tue, 23 Apr 2024
Outcome of Board Meeting-XBRL
REMUS PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 23-Apr-2024 for Dividend/Bonus Shares

Remus Pharmaceuticals Ltd. Technical Scans

Wed, 24 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing 52 Week High Close Crossing 52 Week High
Opening at Low Opening at Low

Remus Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,140.18 1,520.15 +2.3%
Cipla Ltd. 112,292.49 1,406.20 +0.6%
Divi's Laboratories Ltd. 101,276.26 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. 99,314.42 6,218.75 +4.5%
Mankind Pharma Ltd. 95,586.41 2,398.55 +0.0%
Zydus Lifesciences Ltd. 93,730.70 951.25 +1.9%
Torrent Pharmaceuticals Ltd. 90,650.92 2,694.30 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.44 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.28 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 73.23 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 55.35 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.52 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.68 2,694.30 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.77 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.34 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 10.76 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.97 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.68 2,694.30 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,694.30 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,694.30 +0.3%

Remus Pharmaceuticals Ltd. FAQ's

What is Remus Pharmaceutical share price?

Can I buy Remus Pharmaceutical shares now?

What is the Dividend Yield of Remus Pharmaceutical?

What is the Market Cap of Remus Pharmaceutical?

What are the key metrics to analyse Remus Pharmaceutical?

What is the 52 Week High and Low of Remus Pharmaceutical?

What is the trend of Remus Pharmaceutical share price?